(Q36695711)

15 August 2017

Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study (English)

1 reference

15 August 2017

Allemani C

1

1 reference

15 August 2017

Sant M

2

1 reference

15 August 2017

Berrino F

3

1 reference

15 August 2017

Aareleid T

4

1 reference

15 August 2017

Chaplain G

5

1 reference

15 August 2017

Coebergh JW

6

1 reference

15 August 2017

Colonna M

7

1 reference

15 August 2017

Contiero P

8

1 reference

15 August 2017

Danzon A

9

1 reference

15 August 2017

Federico M

10

1 reference

15 August 2017

Federico M

11

1 reference

15 August 2017

Gafà L

12

1 reference

15 August 2017

Grosclaude P

13

1 reference

15 August 2017

Hédelin G

14

1 reference

15 August 2017

Macè-Lesech J

15

1 reference

15 August 2017

Garcia CM

16

1 reference

15 August 2017

Paci E

17

1 reference

15 August 2017

Raverdy N

18

1 reference

15 August 2017

Tretarre B

19

1 reference

15 August 2017

Williams EM

20

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

91

1 reference

15 August 2017

7

1 reference

15 August 2017

1263-1268

1 reference

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

The standardization of estrogen receptors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

A computer program package for relative survival analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

Tubular carcinoma of the breast

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

The relation between survival and age at diagnosis in breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

Prognosis in breast cancer: the effect of age and menstrual status

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

Breast carcinoma survival in Europe and the United States

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

Risk factors for breast cancer according to estrogen and progesterone receptor status

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

Regression models for relative survival

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

Risk of Mortality by Histologic Type of Breast Cancer Among Women Aged 50 to 79 Years

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

Cancer survival corrected for heterogeneity in patient withdrawal.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409902

Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602153

Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas

21 January 2018

1 reference

12 December 2020

Differences in stage and therapy for breast cancer across Europe

1 reference

12 December 2020

Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer

1 reference

12 December 2020

Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria

1 reference

12 December 2020

Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences

1 reference

12 December 2020

Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up

1 reference

12 December 2020

Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?

1 reference

12 December 2020

Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases

1 reference

12 December 2020

An investigation of cut-points for primary breast cancer oestrogen and progesterone receptor assays

1 reference

12 December 2020

Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer

1 reference

12 December 2020

The importance of histologic type on breast cancer survival

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6602153

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

15365566

1 reference